دورية أكاديمية

The critical pharmaceutical situation in Sudan 2023: A humanitarian catastrophe of civil war.

التفاصيل البيبلوغرافية
العنوان: The critical pharmaceutical situation in Sudan 2023: A humanitarian catastrophe of civil war.
المؤلفون: Hemmeda, Lina, Tiwari, Angad, Kolawole, Barakat Olajumoke, Ayoobkhan, Fathima Shehnaz, Fatima, Kainat, Shabani, Moshi Moshi, Kundu, Mrinmoy, Anugu, NagaSpurthy Reddy, Richard, Riya Mary, Ibrahim, Danya, Ahmed, Khabab Abbasher Hussien Mohamed
المصدر: International Journal for Equity in Health; 3/13/2024, Vol. 23 Issue 1, p1-6, 6p
مصطلحات موضوعية: WAR, INVENTORY shortages, CRISIS intervention (Mental health services), PHARMACEUTICAL industry, DRUGS, MEDICAL needs assessment, GOVERNMENT regulation, HUMANITARIANISM, COVID-19 pandemic
مصطلحات جغرافية: SUDAN
مستخلص: The situation in Sudan have deteriorated since the ongoing war outbreak in April 2023. This article sheds light on the pharmacological status in Sudan in terms of shortage of supply, rising demands, and regulatory issues. The ongoing civil war has acutely impacted the dilapidated pharmaceutical status of Sudan, patients have suffered from the paucity of medical services forcing an out-of-control rise in underreported morbidity and mortality. To mitigate this uprising issue, an increase in stakeholder communication is crucial to deal with this national threat and establish a system for reporting the shortage. [ABSTRACT FROM AUTHOR]
Copyright of International Journal for Equity in Health is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14759276
DOI:10.1186/s12939-024-02103-9